tirzepatide vs. semaglutide for weight loss Semaglutide: Understanding Your Medication Options Semaglutide vs Tirzepatide results

Based on findings from the STEP research team, who compared the drug's impact with a placebo, it's estimated that 90% of patients receiving Wegovy will manifest a positive response in the preliminary phase (a minimum of 5% weight loss within 5 months).The projected average weight loss hovers around 20% following 68 weeks of administration

Today, regulatory changes and growing clinical evidence are shifting that landscape

Oral ketamine for the treatment of pain and treatment-resistant depression

Many of these side effects dissipate with chronic treatment

The Problem with Muscle Loss Muscle tissue is metabolically expensive

It exists primarily as a clinician-directed, patient-tolerated approach that some prescribers use off-label